TME

Oct 18 2024BUSINESS

The Power Trio of AI Investing: Kutcher, Epstein, and Oseary at Disrupt 2024

Ever wondered who's banking on AI's bright future? Enter Ashton Kutcher, Effie Epstein, and Guy Oseary – the dream team behind Sound Ventures. This Beverly Hills-based firm turned heads last year with a whopping $265 million AI fund, targeting just six big-league companies like OpenAI and Hugging Fa

reading time less than a minute
Oct 18 2024POLITICS

Ukraine's Army Uses Ads to Attract New Recruits

In Ukraine, the military is using unique methods to attract new soldiers. For instance, a giant billboard in Kharkiv features a stylish woman with a gun, riding on a motorcycle with a soldier. This isn't your typical military recruitment ad; it's more like something you'd see for a new perfume. The

reading time less than a minute
Oct 18 2024FINANCE

Seeing Patterns: Why Some Stocks Can Feel Like a Bet

Investment strategist Doug Cohen from Fiduciary Trust International covered a lot of ground in a recent interview with Quartz. Talking about the volatile world of stocks, especially those related to Trump Media, he highlighted the speculative nature of such investments. How can you tell if a stock

reading time less than a minute
Oct 18 2024POLITICS

Texas AG Targets Dallas Doctor Over Teen Trans Care

Texas Attorney General Ken Paxton is making waves by suing a Dallas pediatrician, Dr. May Lau. He says she's breaking state law by giving hormone treatments to teens trying to transition their gender. Paxton claims these treatments are harmful and irreversible. The law he's using, SB 14, was passed

reading time less than a minute
Oct 18 2024FINANCE

Microsoft's Untapped Potential: A Turnaround Story

JR Research, a top analyst in the tech and software sectors, sees Microsoft as a promising investment opportunity. He focuses on finding growth stocks with strong potential and bargain prices. Microsoft, once a high-flyer, has taken a hit recently. But JR Research believes this could be a chance to

reading time less than a minute
Oct 18 2024BUSINESS

Microsoft's Upcoming Earnings: Expect the Unexpected

Ever wondered how the tech giant Microsoft is doing? Well, the latest buzz is all about their quarterly earnings report coming up soon. Experts like Daniel Sereda, who works for a family office investing across continents, are busy sifting through mountains of data to get a clear picture. Why shoul

reading time less than a minute
Oct 18 2024FINANCE

Microsoft: Time to Explore New Options

Have you ever heard the phrase, "Don't put all your eggs in one basket"? Well, that's exactly what some investors are starting to think about Microsoft (MSFT). Back in April 2024, when the stock was dropping from its high of $429. 37, some experts suggested that Microsoft might face some bumps in th

reading time less than a minute
Oct 18 2024HEALTH

New Ways to Prevent HIV: Injectables vs. Pills

HIV prevention has come a long way. Safe sex practices, like using condoms and reducing partners, are still key. Surgical methods, like male circumcision, can also help. Treating infections is another preventive measure. But, people don't always use these methods. That's why scientists are exploring

reading time less than a minute
Oct 18 2024FINANCE

BlackRock's Big Move: Should You Invest?

Meet BlackRock, a giant in the financial world that's been making waves. The company, which manages over $11 trillion in assets, just crushed expectations with its latest quarterly earnings. CEO Larry Fink shared that the firm added a massive $2 trillion organically over the past five years, making

reading time less than a minute
Oct 18 2024BUSINESS

Biotech Moves: Layoffs, Deals, and Drug Concerns

Let's take a look at what's been happening in the biotech world today. Sage Therapeutics is cutting its workforce by a third and changing its leadership. Why? Recent clinical trial failures have likely played a role. Over in Australia, regulators have rejected Eisai and Biogen's Alzheimer's drug, L

reading time less than a minute